The level of mTORC2 downstream AKT phosphorylation was not altered by KR treatment (Supplementary Figure S2), indicating that DPP-4 suppression targets the mTORC1 pathway rather than mTORC2 in breast cancer cells. Here, DPP4 is linked to breast cancer.